📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. (2018)

First Author: Offman J

Attributed to: Oesophago-gastric adenocarcinoma: understanding disease pathogenesis and applications to earlier diagnosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12885-018-4664-3

PubMed Identifier: 30075763

Publication URI: http://europepmc.org/abstract/MED/30075763

Type: Journal Article/Review

Volume: 18

Parent Publication: BMC cancer

Issue: 1

ISSN: 1471-2407